NCT05970237招募中不适用
A Multicenter, Prospective, Non-interventional, Observational Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 9,000
- 试验地点
- 1
- 主要终点
- Target blood pressure control rate
研究概览
简要总结
The purpose of this clinical trial is to evaluate the efficacy and safety of dapagliflozin in patient with type 2 diabetes mellitus and hypertension
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Those diagnosed with type 2 diabetes mellitus accompanied by hypertension who are scheduled to be administrated Trudapa Tab. or Trudapa M SR Tab.
- •Those who voluntarily signed a written personal information agreement to participate in this clinical study.
- •Those able to understand this study, be cooperative in the execution of the study, and participate in the study until its completion.
排除标准
- •Patients with secondary hypertension: Secondary hypertension is not limited to the following diseases; (e.g., coarctation of the aorta, hyperaldosteronism, renal artery stenosis, pheochromocytoma, Cushing's syndrome and polycystic kidney disease, etc.)
- •Those who have a history of taking dapagliflozin within 4 weeks of baseline (Visit 1)
- •Those who are expected to need insulin prescription during the study period
- •Pregnant women, breast-feeding women
结局指标
主要结局
Target blood pressure control rate
时间窗: 12weeks after administration
Target blood glucose achievement rate
时间窗: 12weeks after administration
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesType 2 Diabetes MellitusNCT02413398AstraZeneca321
已完成
4 期
The Fontan Dapagliflozin Pilot StudyHeart FailureNCT05741658Johns Hopkins University29
已完成
3 期
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseType 2 DiabetesNCT00528372AstraZeneca1,067
已完成
3 期
Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney DiseaseChronic Kidney DiseasesNCT05196347Kaohsiung Medical University180
已完成
2 期
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal ImpairmentDiabetes Mellitus, Type 2NCT00663260AstraZeneca631